§ 13F · FUND PROFILE
Foresite Capital Management IV, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $124M (13F)Positions · 6Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$21M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | PHVS | Pharvaris N.V. | 4.78M | $135M | 56.9% | ±0% |
| 2 | CYTK | CYTOKINETICS INC | 503K | $33M | 14.0% | +10% |
| 3 | EIKN | Eikon Therapeutics, Inc. | 1.94M | $21M | 8.7% | NEW |
| 4 | LYEL | Lyell Immunopharma, Inc. | 800K | $16M | 6.8% | ±0% |
| 5 | RLAY | Relay Therapeutics, Inc. | 1.00M | $10M | 4.2% | ±0% |
| 6 | XENE | Xenon Pharmaceuticals Inc. | 160K | $9M | 3.9% | ±0% |
| 7 | ALEC | Alector, Inc. | 3.89M | $8M | 3.5% | ±0% |
| 8 | MAZE | Maze Therapeutics, Inc. | 157K | $5M | 2.0% | −70% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FORESITE SIGNAL
AC read
Foresite Capital Management IV, LLC is a Other fund managing $124 million in assets. The fund runs a focused portfolio of just 6 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed